BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Keppra®: Changed dose recommendations

2010.02.01

Active substance: levetiracetam

Changed dose recommendations for use in children and adults are valid.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 1MB, File is accessible